Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Dottikon Es Holding AG    DESN   CH0020739006

DOTTIKON ES HOLDING AG

(DESN)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Dottikon Es : Shareholders Approve all Proposals of the Board of Directors

share with twitter share with LinkedIn share with facebook
07/03/2020 | 03:04pm EDT

MEDIA RELEASE

Dottikon, July 3, 2020

DOTTIKON ES' Shareholders Approve all Proposals of the Board of Directors

Dottikon, Switzerland, July 3, 2020 - Due to the coronavirus pandemic, DOTTIKON ES HOLDING AG's 15th Annual General Meeting took place without the physical presence of the shareholders, who sent in their voting instructions electronically or via mail and approved all proposals of the Board of Directors. The 486 shareholders who participated in the vote represented 1'167'196 voting rights and therefore 95.8% of the total of 1'218'484 registered shares with voting rights.

The Annual Report, the financial statements 2019/20, and the Group financial statements 2019/20 of DOTTIKON ES HOLDING AG were approved by the Annual General Meeting. In ad-dition, the retrospective approval of the remuneration of the advisory counselor according to the Compensation Report 2019/20 was accepted. The Compensation Report 2019/20 was presented to and taken notice of by the Annual General Meeting. Discharge for the business year 2019/20 was granted to the responsible members of the Board of Directors and Senior Management.

Further, the proposal of the Board of Directors to carry forward the entire retained earnings to new account and to pay no dividend was accepted. The previous Chairman of the Board of Directors Dr. Markus Blocher was confirmed for another one-year term. In addition, Dr. Alfred Scheidegger, now in the function of Deputy Chairman, was reelected for a one-year term. Dr. Bernhard Urwyler, former advisory counselor, was elected as a new member of the Board of Directors for a one-year term. Given the circumstances, the Annual General Meeting was unable to give former Deputy Chairman Dr. Thomas Früh an official farewell. The Board of Directors and the Senior Manage-ment therefore seize this opportunity to thank him for his fact-based, pragmatic approach during his 8-year tenure as Deputy Chairman of the Board of Directors. His operational activities and broad experience as CEO of Bachem Group made a great contribution and have helped bring DOTTIKON ahead. All three Board members were also elected for a term of one year as members of the Compensation Committee. Dr. Markus Blocher was elected as its Chairman and Dr. Alfred Scheidegger as Deputy Chairman. The proposed maximum amounts of prospective remunera-tions for the Board of Directors and Senior Management, respectively, were approved. KPMG AG, Zug, was reelected as external auditor for another one-year term. Dr. iur. Michael Wicki, attorney-at-law and notary public, was reelected as independent proxy for the 16th Annual General Meet-ing.

DOTTIKON ES manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader. Its safety culture created over the past 105 years guides the innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous pro-cessing in order to challenge, tighten, or shorten conventional chemical synthesis routes, improve selectivities, yields, and purities, and reduce waste. The versatile technology and equipment port-folio is used, maintained, and continuously expanded to design, develop, and optimize chemical processes and technical manufacturing procedures for the rapid scale-up from kilograms to multi-tons in order to produce and deliver the respective market volumes.

DOTTIKON ES' one-site strategy allows reduced decision and communication pathways. This ensures rapid and efficient project development as well as clear and transparent data and process documentation and customer communication.

DOTTIKON ES HOLDING AG is listed on the SIX Swiss Exchange. Symbol: DESN

Security number: 2073900 ISIN: CH0020739006

For further information please contact

Markus Blocher, Ph.D.

CEO

Dottikon ES Holding AG

Tel +41 56 616 82 01 Fax +41 56 616 89 45investor-relations@dottikon.com

Disclaimer

Dottikon ES Holding AG published this content on 03 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 July 2020 18:03:02 UTC


share with twitter share with LinkedIn share with facebook
All news about DOTTIKON ES HOLDING AG
07/03DOTTIKON ES : Shareholders Approve all Proposals of the Board of Directors
PU
05/29DOTTIKON ES : Condensed Annual Report 2019/20
PU
05/29DOTTIKON ES : Higher Sales and Net Income – Investments in Further Growth
PU
05/26DOTTIKON ES HOLDING AG : annual earnings release
2019DOTTIKON ES : Markus Blocher Reorganizes Equity Interest Structure, Increases To..
PU
2019HALF-YEAR REPORT 2019/20 : Strong Growth and Significant Net Income Increase
PU
2019DOTTIKON ES : Condensed Half-Year Report 2019/20
PU
2019DOTTIKON ES : Handover of Processes & Technologies Senior Management Position
PU
2019DOTTIKON ES : Shareholders Approve all Proposals of the Board of Directors
PU
2019ANNUAL REPORT 2018/19 : Stronger Second Half-Year, Full Business Year Below Prev..
PU
More news
Financials
Sales 2020 175 M 193 M 193 M
Net income 2020 33,2 M 36,6 M 36,6 M
Net cash 2020 42,8 M 47,2 M 47,2 M
P/E ratio 2020 24,3x
Yield 2020 -
Capitalization 1 401 M 1 545 M 1 544 M
EV / Sales 2019 3,47x
EV / Sales 2020 4,36x
Nbr of Employees 606
Free-Float 21,1%
Chart DOTTIKON ES HOLDING AG
Duration : Period :
Dottikon Es Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DOTTIKON ES HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers
NameTitle
Markus Blocher Chairman, Chief Executive Officer & MD
Marlene Born Chief Financial Officer
Urs Brändli Head-Processes & Technologies
Alfred Scheidegger Non-Executive Director
Stephan Kirschbaum Head-Business Development
Sector and Competitors
1st jan.Capitalization (M$)
DOTTIKON ES HOLDING AG107.07%1 699
MERCK KGAA25.15%67 857
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD104.14%21 282
KYOWA KIRIN CO., LTD.1.79%13 360
BETTA PHARMACEUTICALS CO., LTD.59.51%6 264
YUHAN CORPORATION24.74%3 346